在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 17 Reference Ions Near m/z 415.2255
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000043158 Reliable 415.2263 415.2261 ~ 415.2268
MzDiff: 2.8 ppm
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026)
Formula: C21H34O8 (414.2254)
14.99 (95%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000052758 Reliable 415.2338 415.2333 ~ 415.234
MzDiff: 2.7 ppm
Riboflavin (Vitamin B2) (BioDeep_00000001427)
Formula: C17H20N4O6 (376.1383)
6.35 (100%) DESI
[NOVOCELL:BACKGROUND] blank
MSI_000063237 Reliable 415.2213 415.2213 ~ 415.2214
MzDiff: 0.1 ppm
7-Hydroxymitragynine (BioDeep_00000175102)
Formula: C23H30N2O5 (414.2155)
5.12 (100%) Mus musculus
[UBERON:0000956] cerebral cortex
MSI_000065060 Reliable 415.2352 415.235 ~ 415.2357
MzDiff: 2.8 ppm
Riboflavin (Vitamin B2) (BioDeep_00000001427)
Formula: C17H20N4O6 (376.1383)
4.06 (100%) DESI
[NOVOCELL:BACKGROUND] blank
MSI_000065184 Reliable 415.2254 415.2251 ~ 415.2256
MzDiff: 1.9 ppm
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026)
Formula: C21H34O8 (414.2254)
5.09 (100%) Homo sapiens
[UBERON:0001155] colon
MSI_000047668 Unreliable 415.2261 415.2261 ~ 415.2261
MzDiff: none
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026)
Formula: C21H34O8 (414.2254)
2.18 (100%) Homo sapiens
[UBERON:0013067] colorectal mucosa
MSI_000051919 Unreliable 415.2275 415.2275 ~ 415.2275
MzDiff: none
(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside (BioDeep_00000020026)
Formula: C21H34O8 (414.2254)
2.38 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000051939 Unreliable 415.2218 415.2218 ~ 415.2218
MzDiff: none
CID 9844747 (BioDeep_00000179081)
Formula: C22H26FN3O4 (415.1907)
2.38 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000052613 Unreliable 415.2325 415.2325 ~ 415.2325
MzDiff: none
Riboflavin (Vitamin B2) (BioDeep_00000001427)
Formula: C17H20N4O6 (376.1383)
1.21 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000053135 Unreliable 415.2177 415.2177 ~ 415.2177
MzDiff: none
Eplerenone (BioDeep_00000002302)
Formula: C24H30O6 (414.2042)
2.93 (100%) DESI
[NOVOCELL:BACKGROUND] blank
MSI_000027486 Unreliable 415.2215 415.2212 ~ 415.2218
MzDiff: 2.7 ppm
7-Hydroxymitragynine (BioDeep_00000175102)
Formula: C23H30N2O5 (414.2155)
3.78 (50%) Mus musculus
[UBERON:0002048] lung
MSI_000025251 Unreliable 415.223 415.223 ~ 415.223
MzDiff: none
Buclizine (BioDeep_00000006601)
Formula: C28H33ClN2 (432.2332)
1.68 (100%) Mus musculus
[UBERON:0004269] upper arm connective tissue
MSI_000055992 Unavailable 415.2349 415.2349 ~ 415.2349
MzDiff: none
Riboflavin (Vitamin B2) (BioDeep_00000001427)
Formula: C17H20N4O6 (376.1383)
-0.47 (100%) Homo sapiens
[UBERON:0007779] transudate
MSI_000056288 Unavailable 415.2267 415.2267 ~ 415.2267
MzDiff: none
Buclizine (BioDeep_00000006601)
Formula: C28H33ClN2 (432.2332)
-0.6 (100%) Homo sapiens
[UBERON:0007779] transudate
MSI_000058570 Unreliable 415.2221 415.2221 ~ 415.2221
MzDiff: none
7-Hydroxymitragynine (BioDeep_00000175102)
Formula: C23H30N2O5 (414.2155)
1.14 (100%) Mus musculus
[UBERON:0001950] neocortex
MSI_000059936 Unavailable 415.2221 415.2221 ~ 415.2221
MzDiff: none
7-Hydroxymitragynine (BioDeep_00000175102)
Formula: C23H30N2O5 (414.2155)
-0.72 (100%) Mus musculus
[UBERON:0002298] brainstem
MSI_000060685 Unavailable 415.2221 415.2221 ~ 415.2221
MzDiff: none
7-Hydroxymitragynine (BioDeep_00000175102)
Formula: C23H30N2O5 (414.2155)
-0.42 (100%) Mus musculus
[UBERON:0002421] hippocampal formation

Found 43 Sample Hits
Metabolite Species Sample
7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 3.2)
Mus musculus (Lung)
image1
Resolution: 40μm, 187x165

Description

Fig. 2 MALDI-MSI data from the same mouse lung tissue analyzed in Fig. 1. A: Optical image of the post-MSI, H&E-stained tissue section. B–D, F–G: Ion images of (B) m/z 796.6855 ([U13C-DPPC+Na]+), (C) m/z 756.5514 ([PC32:0+Na]+), (D) m/z 765.6079 ([D9-PC32:0+Na]+), (F) m/z 754.5359 ([PC32:1+Na]+), and (G) m/z 763.5923 ([D9-PC32:1+Na]+). E, H: Ratio images of (E) [D9-PC32:0+Na]+:[PC32:0+Na]+ and (H) [D9-PC32:1+Na]+:[PC32:1+Na]+. Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. U13C-DPPC, universally 13C-labeled dipalmitoyl PC; PC, phosphatidylcholine; MSI, mass spectrometry imaging; H&E, hematoxylin and eosin. Fig 1-3, Fig S1-S3, S5

Buclizine

Formula: C28H33ClN2 (432.2332)
Adducts: [M+H-H2O]+ (Ppm: 16.7)
Mus musculus (Left upper arm)
357_l_total ion count
Resolution: 50μm, 97x131

Description

Diseased

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 3.7)
Mus musculus (Lung)
image3
Resolution: 40μm, 146x190

Description

Fig. 4 MALDI-MSI data of mouse lung tissue after administration with D9-choline and U13C-DPPC–containing Poractant alfa surfactant (labels administered 12 h prior to tissue collection). Ion images of (A) m/z 796.6856 ([U13C-DPPC+Na]+), (B) m/z 756.5154 [PC32:0+Na]+), and (C) m/z 765.6079 ([D9-PC32:0+Na]+). D: Overlay image of [U13C-PC32:0+Na]+ (red) and [D9-PC32:0+Na]+ (green). Part-per-million (ppm) mass errors are indicated in parentheses. All images were visualized using total-ion-current normalization and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC.

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 3.7)
Mus musculus (Lung)
image4
Resolution: 40μm, 162x156

Description

Fig 6c Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC.

Buclizine

Formula: C28H33ClN2 (432.2332)
Adducts: [M+H-H2O]+ (Ppm: 19.6)
Mus musculus (Lung)
image2
Resolution: 40μm, 550x256

Description

Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b) [PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9- choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using total ion current normalisation and hotspot removal (high quantile = 99%).

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.5)
Homo sapiens (esophagus)
LNTO22_1_3
Resolution: 75μm, 121x68

Description

Buclizine

Formula: C28H33ClN2 (432.2332)
Adducts: [M+H-H2O]+ (Ppm: 13.3)
Homo sapiens (esophagus)
LNTO22_1_4
Resolution: 17μm, 82x80

Description

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 6.9)
Homo sapiens (esophagus)
LNTO29_16_2
Resolution: 17μm, 95x101

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 14)
Homo sapiens (esophagus)
LNTO22_1_9
Resolution: 75μm, 89x74

Description

Buclizine

Formula: C28H33ClN2 (432.2332)
Adducts: [M+H-H2O]+ (Ppm: 14.3)
Mus musculus (Liver)
Salmonella_final_pos_recal
Resolution: 17μm, 691x430

Description

A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium. [dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671.

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 17.2)
Homo sapiens (esophagus)
LNTO30_8M_1
Resolution: 17μm, 69x54

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.7)
Homo sapiens (colorectal adenocarcinoma)
80TopL, 50TopR, 70BottomL, 60BottomR-profile
Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Eplerenone

Formula: C24H30O6 (414.2042)
Adducts: [M+H]+ (Ppm: 19)
Homo sapiens (colorectal adenocarcinoma)
520TopL, 490TopR, 510BottomL, 500BottomR-profile
Resolution: 17μm, 147x131

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Riboflavin (Vitamin B2)

Formula: C17H20N4O6 (376.1383)
Adducts: [M+K]+ (Ppm: 17.7)
Homo sapiens (colorectal adenocarcinoma)
520TopL, 490TopR, 510BottomL, 500BottomR-profile
Resolution: 17μm, 147x131

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

CID 9844747

Formula: C22H26FN3O4 (415.1907)
Adducts: [M-H2O+NH4]+ (Ppm: 18.8)
Homo sapiens (colorectal adenocarcinoma)
439TopL, 409TopR, 429BottomL, 419BottomR-profile
Resolution: 17μm, 157x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

CID 9844747

Formula: C22H26FN3O4 (415.1907)
Adducts: [M-H2O+NH4]+ (Ppm: 11.1)
Homo sapiens (NA)
160TopL,130TopR,150BottomL,140BottomR-profile
Resolution: 17μm, 142x136

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 16.9)
Homo sapiens (NA)
160TopL,130TopR,150BottomL,140BottomR-profile
Resolution: 17μm, 142x136

Description

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 6.4)
Homo sapiens (esophagus)
LNTO29_16_3
Resolution: 17μm, 108x107

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.3)
Homo sapiens (esophagus)
LNTO26_7_1
Resolution: 17μm, 75x74

Description

Buclizine

Formula: C28H33ClN2 (432.2332)
Adducts: [M+H-H2O]+ (Ppm: 7.8)
Homo sapiens (esophagus)
LNTO26_7_2
Resolution: 17μm, 135x101

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.7)
Homo sapiens (esophagus)
LNTO26_7_3
Resolution: 75μm, 82x88

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 17.2)
Homo sapiens (esophagus)
TO31T
Resolution: 75μm, 56x54

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.5)
Homo sapiens (esophagus)
TO29T
Resolution: 75μm, 56x48

Description

Buclizine

Formula: C28H33ClN2 (432.2332)
Adducts: [M+H-H2O]+ (Ppm: 10.7)
Homo sapiens (esophagus)
TO41T
Resolution: 75μm, 69x43

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 16.9)
Homo sapiens (esophagus)
LNTO30_8M_2
Resolution: 75μm, 108x68

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 16.9)
Homo sapiens (esophagus)
LNTO30_8M_3
Resolution: 75μm, 69x54

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 16.2)
Homo sapiens (esophagus)
LNTO30_8M_4
Resolution: 75μm, 62x48

Description

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 6.9)
Homo sapiens (esophagus)
LNTO30_8M_5
Resolution: 75μm, 56x54

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 16.7)
Homo sapiens (esophagus)
LNTO30_17_2
Resolution: 75μm, 82x54

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 14.8)
Homo sapiens (esophagus)
LNTO22_1_5
Resolution: 75μm, 135x94

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.7)
Homo sapiens (esophagus)
LNTO22_1_8
Resolution: 75μm, 69x61

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.7)
Homo sapiens (esophagus)
LNTO22_2_1
Resolution: 75μm, 89x88

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 14.8)
Homo sapiens (esophagus)
LNTO22_2_2
Resolution: 75μm, 135x94

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 15.5)
Homo sapiens (esophagus)
LNTO26_16_1
Resolution: 75μm, 95x88

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 17.4)
Homo sapiens (esophagus)
LNTO29_18_2
Resolution: 75μm, 62x68

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 16.7)
Homo sapiens (esophagus)
LNTO30_7_1
Resolution: 75μm, 69x68

Description

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 7.1)
Homo sapiens (esophagus)
LNTO30_7_2
Resolution: 75μm, 82x68

Description

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 1.5)
Mus musculus (brain)
Brain01_Bregma-3-88b_centroid
Resolution: 17μm, 265x320

Description

7-Hydroxymitragynine

Formula: C23H30N2O5 (414.2155)
Adducts: [M+H]+ (Ppm: 3.5)
Mus musculus (brain)
Brain02_Bregma1-42_03
Resolution: 17μm, 483x403

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 17.7)
Homo sapiens (colorectal adenocarcinoma)
240TopL, 210TopR, 230BottomL, 220BottomR-centroid
Resolution: 50μm, 142x141

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 16.9)
Homo sapiens (colorectal adenocarcinoma)
200TopL, 170TopR, 190BottomL, 180BottomR-centroid
Resolution: 50μm, 132x126

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 18.1)
Homo sapiens (colorectal adenocarcinoma)
160TopL,130TopR,150BottomL,140BottomR-centroid
Resolution: 50μm, 142x136

Description

(4R,5S,7R,11x)-11,12-Dihydroxy-1(10)-spirovetiven-2-one 12-glucoside

Formula: C21H34O8 (414.2254)
Adducts: [M+H]+ (Ppm: 17.2)
Homo sapiens (colorectal adenocarcinoma)
120TopL, 90TopR, 110BottomL, 100BottomR-centroid
Resolution: 50μm, 132x136

Description